Literature DB >> 477735

3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors.

I Creese, L Padgett, E Fazzini, F Lopez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 477735     DOI： 10.1016/0014-2999(79)90274-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  8 in total

Review 1.  A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride.

Authors:  Jennifer L Martelle; Michael A Nader
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

Review 2.  Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.

Authors:  Jan-Peter van Wieringen; Jan Booij; Vladimir Shalgunov; Philip Elsinga; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-09       Impact factor: 3.000

3.  Kinetic properties of the in vivo accumulation of 3H-(-)-N-n-propylnorapomorphine in mouse brain.

Authors:  S B Ross; D M Jackson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

4.  Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.

Authors:  D R Sibley; S Weinberger; D S Segal; I Creese
Journal:  Experientia       Date:  1982-10-15

5.  Agonist-induced subsensitivity of adenylate cyclase coupled with a dopamine receptor in slices from rat corpus striatum.

Authors:  M Memo; W Lovenberg; I Hanbauer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

6.  Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study.

Authors:  X M Li; L Ferraro; S Tanganelli; W T O'Connor; U Hasselrot; U Ungerstedt; K Fuxe
Journal:  J Neural Transm Gen Sect       Date:  1995

7.  Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.

Authors:  K Fuxe; L F Agnati; C Köhler; D Kuonen; S O Ogren; K Andersson; T Hökfelt
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

8.  Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.

Authors:  W H Riffee; R E Wilcox; D M Vaughn; R V Smith
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.